BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 16167546)

  • 1. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
    Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
    Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
    Preusser M; Budka H; Rössler K; Hainfellner JA
    Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
    Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA
    Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
    Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
    Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.
    Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG
    Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraventricular neurocytoma in a child mimicking oligodendroglioma: a diagnostic pitfall.
    Limaiem F; Bellil S; Chelly I; Mekni A; Bellil K; Jemel H; Haouet S; Zitouna M; Kchir N
    Pathologica; 2009 Apr; 101(2):105-7. PubMed ID: 19886559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
    Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
    Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
    Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
    Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
    J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
    Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].
    Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR
    Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.
    Kocaeli H; Yakut T; Bekar A; Taşkapilioğlu O; Tolunay S
    Surg Neurol; 2006 Dec; 66(6):627-30; discussion 630-1. PubMed ID: 17145331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor.
    Makuria AT; Henderson FC; Rushing EJ; Hartmann DP; Azumi N; Ozdemirli M
    J Neurooncol; 2007 Apr; 82(2):199-205. PubMed ID: 17039400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion status.
    Sherman JH; Prevedello DM; Shah L; Raghavan P; Pouratian N; Starke RM; Lopes MB; Shaffrey ME; Schiff D
    Acta Neurochir (Wien); 2010 Nov; 152(11):1827-34. PubMed ID: 20711790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of oligodendroglioma with prominent neuronal differentiation.
    Hirose T; Nobusawa S; Nakazato Y; Sasaki A
    Hum Pathol; 2013 Oct; 44(10):2353-9. PubMed ID: 24054724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome.
    Kros JM; Gorlia T; Kouwenhoven MC; Zheng PP; Collins VP; Figarella-Branger D; Giangaspero F; Giannini C; Mokhtari K; Mørk SJ; Paetau A; Reifenberger G; van den Bent MJ
    J Neuropathol Exp Neurol; 2007 Jun; 66(6):545-51. PubMed ID: 17549014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss.
    Mrak RE; Yasargil MG; Mohapatra G; Earel J; Louis DN
    Hum Pathol; 2004 Sep; 35(9):1156-9. PubMed ID: 15343519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
    Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
    Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.
    Barbashina V; Salazar P; Ladanyi M; Rosenblum MK; Edgar MA
    Am J Surg Pathol; 2007 Aug; 31(8):1196-202. PubMed ID: 17667543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.